This months Living Beyond Dementia™ blog (yes, only one again as I am too busy living beyond dementia), is on the following study (Abstract and Summary only included – follow the link to the full study),

Reversal of cognitive decline: A novel therapeutic program

Dale E. Bredesen^{1, 2}

¹ Mary S. Easton Center for Alzheimer’s Disease Research, Department of Neurology, University of California, Los Angeles, CA 90095;

² Buck Institute for Research on Aging, Novato, CA 94945.

Abstract

This report describes a novel, comprehensive, and personalized therapeutic program that is based on the underlying pathogenesis of Alzheimer’s disease, and which involves multiple modalities designed to achieve metabolic enhancement for neurodegeneration (MEND). The first 10 patients who have utilized this program include patients with memory loss associated with Alzheimer’s disease (AD), amnestic mild cognitive impairment (aMCI), or subjective cognitive impairment (SCI). Nine of the 10 displayed subjective or objective improvement in…